| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.073 | 0.7 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |